Orthofix International | OFIX - Equity Capital And Reserves


Orthofix International reported $450.04M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Accuray USD 61.87M 19.3M Sep/2025
AngioDynamics USD 176.33M 2.52M Sep/2025
Artivion USD 448.23M 9.54M Dec/2025
AtriCure USD 491.94M 15.43M Dec/2025
Dexcom USD 2.75B 19.9M Dec/2025
EDAP TMS EUR 23.32M 4.5M Sep/2025
Globus Medical USD 4.57B 174.42M Dec/2025
Hologic USD 5.25B 197.2M Dec/2025
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 5.89M Dec/2025
J&J USD 78.47B 0 Sep/2025
Medtronic USD 48.99B 128M Dec/2025
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Orthofix International USD 450.04M 7.55M Dec/2025
Plus Therapeutics USD -1.35M 3.97M Dec/2023
Smith & Nephew USD 5.54B 331M Dec/2025
STAAR Surgical USD 344.18M 9.6M Dec/2025
Stryker USD 21.78B 594M Sep/2025
Surmodics USD 118.9M 753K Sep/2024
Tandem Diabetes Care USD 155.17M 22.2M Dec/2025
Teleflex USD 3.12B 697.09M Dec/2025
Veracyte USD 1.26B 36.61M Sep/2025
Zimmer Biomet Holdings USD 12.7B 68.3M Dec/2025